Loading...
XHKG
0926
, Last price  
HKD
Name

Besunyen Holdings Co Ltd

Chart & performance

D1W1MN
XHKG:0926 chart
P/E
—
P/S
—
EPS
0.17
Vol. 1Y
—
Shs. 5Y
15.71%
Rev. 5Y
-17.49%
Div Yld LY
—
Div Yld TTM
—
Revenues
494m
+2.07%
646,535,000874,216,000840,409,000475,182,000487,500,000563,888,000662,805,000514,749,000542,870,000378,378,000812,160,0001,292,711,0001,101,150,000801,342,000542,876,000484,301,000494,322,000
Net income
20m
+38.09%
141,707,00059,655,000-40,876,000-342,187,000-89,976,00045,035,00092,291,000-68,714,0004,086,000-95,299,000162,348,00045,479,000-145,713,000-99,089,000-299,243,00014,804,00020,443,000
CFO
66m
+526.68%
96,564,000181,302,000-64,092,00028,778,0008,968,000109,200,00063,446,000-44,623,000-738,000-82,138,000-42,921,00075,147,000-145,518,00038,111,0009,985,00010,538,00066,039,415
Dividend
Aug 27, 20250.15 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Besunyen Holdings Company Limited, established in Beijing, China, in 2000, functions as a subsidiary of Foreshore Holding Group Limited. The company's core operations encompass the research, development, production, and distribution of therapeutic tea products and pharmaceutical goods throughout the People's Republic of China. Its product range includes a variety of therapeutic teas, prominently featuring the Besunyen brand, alongside specific offerings such as herbal tea, Besunyen Detox, and Besunyen slimming tea. Furthermore, functional teas, such as Besunyen Fit Tea, are also part of its portfolio. Within its pharmaceutical segment, Besunyen markets LARLLY Orlistat for weight loss and manufactures and sells over-the-counter (OTC) medications, including the Besunyen Orlistat weight-loss capsule. Its products reach consumers via an extensive distribution network that includes OTC pharmacies, retail locations in shopping centers and supermarkets, a network of distributors and sub-distributors, and various online e-commerce channels.

Key people

Yihong Zhao
Executive Chairman of the Board, Chief Executive Officer
Juan Wang
Chief Financial Officer · since 2013
Yuanhua Zhao
Chief Operating Officer · since 2014
Ruhai Lin
Vice President - public relationships, new products development and administrative functions
Jeiching Win
Vice President - New Business and New Products Overseas · since 2013
Hongjiang Yu
Vice President - Audit and Legal
Lap Ming Au
Company Secretary · since 2010
Yan Gao
Executive Vice Chairman of the Board
Non-Executive Director · since 2010
Non-Executive Director · since 2009
Non-Executive Independent Director · since 2019
Independent Non-Executive Director · since 2016
Independent Non-Executive Director · since 2010
Independent non-executive Directors · since 2014
IPO date
Sep 29, 2010
Employees
802
Domiciled in
CN
Incorporated in
KY

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT